NovaBay Pharmaceuticals Inc (NYSE American:NBY)

3.40
Delayed Data
As of Feb 23
 0.00 / 0.00%
Today’s Change
2.25
Today|||52-Week Range
5.00
-11.69%
Year-to-Date

Stock Price Forecast

The 4 analysts offering 12-month price forecasts for NovaBay Pharmaceuticals Inc have a median target of 6.13, with a high estimate of 8.00 and a low estimate of 5.00. The median estimate represents a +80.15% increase from the last price of 3.40.

Analyst Recommendations

The current consensus among 4 polled investment analysts is to Buy stock in NovaBay Pharmaceuticals Inc. This rating has held steady since February, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.05
Sales
$6.0M
Reporting Date
TBD

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 70.83%
 
 
 
 
 
 
Growthannually 59.05%
 
 
 
 
 
 

Sales

Growthquarterly 46.09%
 
 
 
 
 
 
Growthannually 50.32%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.